Health
Drug Tariffs Will Harm Patients, AstraZeneca Chairman Says
Michel Demare
Photographer: Luke MacGregor/Bloomberg
This article is for subscribers only.
Tariffs on pharmaceuticals would hurt patients and drugs should be exempt from these levies, AstraZeneca Plc’ Chairman Michel Demaré said.
US President Donald Trump has warned that tariffs on pharmaceutical companies — which weren’t part of the so-called reciprocal tariffs he imposed and then paused — are imminent.